Cargando...
Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel disease
Inflammatory bowel disease (IBD) is a chronic relapsing disease in gastrointestinal tract. Conventional medications lack the efficacy to offer complete remission in IBD therapy, and usually associate with serious side effects. Recent studies indicated that nanoparticle-based nanotherapeutics may off...
Gardado en:
| Publicado en: | World J Gastroenterol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Baishideng Publishing Group Inc
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5016370/ https://ncbi.nlm.nih.gov/pubmed/27678353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i34.7718 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|